Formyl-peptide receptor 2/3/Lipoxin A4 receptor regulates neutrophil-platelet aggregation and attenuates cerebral inflammation: Impact for therapy in cardiovascular disease

Circulation

Volumn 133, Issue 22, 2016, Pages 2169-2179

  Vital, Shantel A ^a   Becker, Felix ^b   Holloway, Paul M ^a   Russell, Janice ^a   Perretti, Mauro ^c   Granger, D Neil ^a   Gavins, Felicity N E ^a,d  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

inflammation; ischemia reperfusion injury; stroke, ischemic

Indexed keywords

ACETYLSALICYLIC ACID; ANNEXIN A1 N TERMINAL DERIVED PEPTIDE; ASPIRIN TRIGGERED LIPOXIN; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR 2; FORMYLPEPTIDE RECEPTOR 3; FORMYLPEPTIDE RECEPTOR LIKE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOXIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; FORMYL PEPTIDE RECEPTOR 2, MOUSE; FPR1 PROTEIN, MOUSE; FPR3 PROTEIN, HUMAN; LIPOCORTIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN HOMOGENATE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN MICROCIRCULATION; CONTROLLED STUDY; DISEASE SEVERITY; ENCEPHALITIS; ENZYME ACTIVITY; GENOTYPE; INFLAMMATION; INTRAVITAL MICROSCOPY; LEUKOCYTE; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LEUKOCYTE COUNT; MICROCIRCULATION; MOUSE; NEUROPROTECTION; NEUTROPHIL; NEUTROPHIL COUNT; NEUTROPHIL PLATELET AGGREGATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; AGONISTS; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CARDIOVASCULAR DISEASES; CEREBRAL INFARCTION; GENETICS; KNOCKOUT MOUSE; PATHOLOGY; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANNEXIN A1; CARDIOVASCULAR DISEASES; CEREBRAL INFARCTION; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; RECEPTORS, FORMYL PEPTIDE;

EID: 84966351090     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.020633     Document Type: Article

References (45)

1. Rodrigues SF, Granger DN, Cerebral microvascular inflammation in DOCA salt-induced hypertension: role of angiotensin II and mitochondrial superoxide. J Cereb Blood Flow Metab 2012 32 368 375. doi: 10.1038/jcbfm.2011.139
2. Serhan CN, Savill J, Resolution of inflammation: the beginning programs the end. Nat Immunol 2005 6 1191 1197. doi: 10.1038/ni1276
3. Trentin PG, Ferreira TP, Arantes AC, Ciambarella BT, Cordeiro RS, Flower RJ, Perretti M, Martins MA, Silva PM, Annexin A1 mimetic peptide controls the inflammatory and fibrotic effects of silica particles in mice. Br J Pharmacol 2015 172 3058 3071. doi: 10.1111/bph.13109
4. Serhan CN, Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 2007 25 101 137. doi: 10.1146/annurev.immunol.25.022106.141647
5. Gavins FN, Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia-reperfusion injury? Trends Pharmacol Sci 2010 31 266 276. doi: 10.1016/j.tips.2010.04.001
6. Chiang N, Serhan CN, Dahlén SE, Drazen JM, Hay DW, Rovati GE, Shimizu T, Yokomizo T, Brink C, The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev 2006 58 463 487. doi: 10.1124/pr.58.3.4
7. Scalia R, Gefen J, Petasis NA, Serhan CN, Lefer AM, Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin. Proc Natl Acad Sci USA 1997 94 9967 9972
8. Gavins FN, Yona S, Kamal AM, Flower RJ, Perretti M, Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. Blood 2003 101 4140 4147. doi: 10.1182/blood-2002-11-3411
9. Gavins FN, Kamal AM, D'Amico M, Oliani SM, Perretti M, Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct. FASEB J 2005 19 100 102. doi: 10.1096/fj.04-2178fje
10. Chiang N, Gronert K, Clish CB, O'Brien JA, Freeman MW, Serhan CN, Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. J Clin Invest 1999 104 309 316. doi: 10.1172/JCI7016
11. Kieran NE, Doran PP, Connolly SB, Greenan MC, Higgins DF, Leonard M, Godson C, Taylor CT, Henger A, Kretzler M, Burne MJ, Rabb H, Brady HR, Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney Int 2003 64 480 492. doi: 10.1046/j.1523-1755.2003.00106.x
12. Smith HK, Gil CD, Oliani SM, Gavins FN, Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke. FASEB J 2015 29 2161 2171. doi: 10.1096/fj.14-263160
13. Gavins FN, Dalli J, Flower RJ, Granger DN, Perretti M, Activation of the annexin 1 counter-regulatory circuit affords protection in the mouse brain microcirculation. FASEB J 2007 21 1751 1758. doi: 10.1096/fj.06-7842com
14. Ishikawa M, Sekizuka E, Yamaguchi N, Nakadate H, Terao S, Granger DN, Minamitani H, Angiotensin II type 1 receptor signaling contributes to platelet-leukocyte-endothelial cell interactions in the cerebral microvasculature. Am J Physiol Heart Circ Physiol 2007 292 H2306 H2315. doi: 10.1152/ajpheart.00601.2006
15. Uyama O, Okamura N, Yanase M, Narita M, Kawabata K, Sugita M, Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J Cereb Blood Flow Metab 1988 8 282 284. doi: 10.1038/jcbfm.1988.59
16. Yipp BG, Kubes P, Antibodies against neutrophil LY6G do not inhibit leukocyte recruitment in mice in vivo. Blood 2013 121 241 242. doi: 10.1182/blood-2012-09-454348
17. Lu SJ, Li F, Yin H, Feng Q, Kimbrel EA, Hahm E, Thon JN, Wang W, Italiano JE, Cho J, Lanza R, Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res 2011 21 530 545. doi: 10.1038/cr.2011.8
18. Yildirim A, Russell J, Yan LS, Senchenkova EY, Granger DN, Leukocyte-dependent responses of the microvasculature to chronic angiotensin II exposure. Hypertension 2012 60 1503 1509. doi: 10.1161/HYPERTENSIONAHA.112.198465
19. Yan SL, Russell J, Harris NR, Senchenkova EY, Yildirim A, Granger DN, Platelet abnormalities during colonic inflammation. Inflamm Bowel Dis 2013 19 1245 1253. doi: 10.1097/MIB.0b013e318281f3df
20. Smith HK, Gavins FN, The potential of stem cell therapy for stroke: is PISCES the sign? FASEB J 2012 26 2239 2252. doi: 10.1096/fj.11-195719
21. Htun P, Fateh-Moghadam S, Tomandl B, Handschu R, Klinger K, Stellos K, Garlichs C, Daniel W, Gawaz M, Course of platelet activation and platelet-leukocyte interaction in cerebrovascular ischemia. Stroke 2006 37 2283 2287. doi: 10.1161/01.STR.0000236638.75591.61
22. Perretti M, Dalli J, Exploiting the annexin A1 pathway for the development of novel anti-inflammatory therapeutics. Br J Pharmacol 2009 158 936 946. doi: 10.1111/j.1476-5381.2009.00483.x
23. Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, Parmentier M, Serhan CN, Murphy PM, International Union of Basic and Clinical Pharmacology, LXXIII: nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 2009 61 119 161. doi: 10.1124/pr.109.001578
24. Gavins FN, Hughes EL, Buss NA, Holloway PM, Getting SJ, Buckingham JC, Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1-FPR2/ALX anti-inflammatory system. FASEB J 2012 26 4977 4989. doi: 10.1096/fj.12-205971
25. Morrison H, McKee D, Ritter L, Systemic neutrophil activation in a mouse model of ischemic stroke and reperfusion. Biol Res Nurs 2011 13 154 163. doi: 10.1177/1099800410384500
26. Yilmaz G, Granger DN, Cell adhesion molecules and ischemic stroke. Neurol Res 2008 30 783 793
27. Buck BH, Liebeskind DS, Saver JL, Bang OY, Yun SW, Starkman S, Ali LK, Kim D, Villablanca JP, Salamon N, Razinia T, Ovbiagele B, Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke 2008 39 355 360. doi: 10.1161/STROKEAHA.107.490128
28. Robinson M, MacHin S, Mackie I, Harrison P, In vivo biotinylation studies: specificity of labelling of reticulated platelets by thiazole orange and mepacrine. Br J Haematol 2000 108 859 864
29. Ault KA, Knowles C, In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Hematol 1995 23 996 1001
30. Cristante E, McArthur S, Mauro C, Maggioli E, Romero IA, Wylezinska-Arridge M, Couraud PO, Lopez-Tremoleda J, Christian HC, Weksler BB, Malaspina A, Solito E, Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications. Proc Natl Acad Sci USA 2013 110 832 841. doi: 10.1073/pnas.1209362110
31. Waje-Andreassen U, Kråkenes J, Ulvestad E, Thomassen L, Myhr KM, Aarseth J, Vedeler CA, IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol Scand 2005 111 360 365. doi: 10.1111/j.1600-0404.2005.00416.x
32. Vila N, Castillo J, Dávalos A, Esteve A, Planas AM, Chamorro A, Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke 2003 34 671 675. doi: 10.1161/01.STR.0000057976.53301.69
33. Brancaleone V, Gobbetti T, Cenac N, le Faouder P, Colom B, Flower RJ, Vergnolle N, Nourshargh S, Perretti M, A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation. Blood 2013 122 608 617. doi: 10.1182/blood-2013-04-496661
34. Cuartero MI, Ballesteros I, Lizasoain I, Moro MA, Complexity of the cell-cell interactions in the innate immune response after cerebral ischemia. Brain Res 2015 1623 53 62. doi: 10.1016/j.brainres.2015.04.047
35. Fierro IM, Colgan SP, Bernasconi G, Petasis NA, Clish CB, Arita M, Serhan CN, Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells. J Immunol 2003 170 2688 2694
36. El Kebir D, Filep JG, Modulation of neutrophil apoptosis and the resolution of inflammation through β2 integrins. Front Immunol 2013 4 60. doi: 10.3389/fimmu.2013.00060
37. Zhou XY, Wu P, Zhang L, Xiong W, Li YS, Feng YM, Ye DY, Effects of lipoxin A(4) on lipopolysaccharide induced proliferation and reactive oxygen species production in RAW264.7 macrophages through modulation of G-CSF secretion. Inflamm Res 2007 56 324 333. doi: 10.1007/s00011-007-7012-7
38. Italiano JE Jr, Mairuhu AT, Flaumenhaft R, Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol 2010 17 578 584. doi: 10.1097/MOH.0b013e32833e77ee
39. Schmalbach B, Stepanow O, Jochens A, Riedel C, Deuschl G, Kuhlenbäumer G, Determinants of platelet-leukocyte aggregation and platelet activation in stroke. Cerebrovasc Dis 2015 39 176 180. doi: 10.1159/000375396
40. Ortiz-Muñoz G, Mallavia B, Bins A, Headley M, Krummel MF, Looney MR, Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice. Blood 2014 124 2625 2634. doi: 10.1182/blood-2014-03-562876
41. Abdulnour RE, Dalli J, Colby JK, Krishnamoorthy N, Timmons JY, Tan SH, Colas RA, Petasis NA, Serhan CN, Levy BD, Maresin 1 biosynthesis during platelet-neutrophil interactions is organ-protective. Proc Natl Acad Sci USA 2014 111 16526 16531. doi: 10.1073/pnas.1407123111
42. Chen K, Iribarren P, Huang J, Zhang L, Gong W, Cho EH, Lockett S, Dunlop NM, Wang JM, Induction of the formyl peptide receptor 2 in microglia by IFN-gamma and synergy with CD40 ligand. J Immunol 2007 178 1759 1766
43. Kostic M, Stojanovic I, Marjanovic G, Zivkovic N, Cvetanovic A, Deleterious versus protective autoimmunity in multiple sclerosis. Cell Immunol 2015 296 122 132. doi: 10.1016/j.cellimm.2015.04.006
44. Heppner FL, Ransohoff RM, Becher B, Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 2015 16 358 372. doi: 10.1038/nrn3880
45. Clària J, Serhan CN, Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 1995 92 9475 9479